康艾注射液配合化疗治疗晚期非小细胞肺癌临床观察

摘要

目的：探讨康艾注射液配合化疗治疗非小细胞肺癌的临床效果。方法：收治晚期非小细胞肺癌患者82例，作为研究对象，根据随机对照原则将其分为两组，对照组和观察组各41例。对照组采用常规的化疗治疗，观察组在此基础上加用康艾注射液，比较两组患者的疗效。结果：观察组有效率46.3%，对照组39.0%，差异不具有统计学意义(P＞0.05)。观察组患者获益率73.2%，明显高于对照组的56.1%(P＜0.05)。观察组不良反应发生率41.5%，明显低于对照组的60.9%(P＜0.05)。结论：针对晚期非小细胞肺癌，采用康艾注射液配合化疗的治疗方案效果良好，基本能够稳定病情，减轻不良反应。%Objective:To explore the clinical effect of Kang Ai injection combined with chemotherapy in the treatment of advanced non-small cell lung cancer.Methods:82 patients with advanced non-small cell lung cancer were selected,and they were as the research objects.According to the random control principle,they were divided into two groups.The control group and the observation group with 41 cases in each.The control group was given the conventional chemotherapy treatment.The observation group was given Kang Ai injection on this basis.The curative effects of two groups were compared.Results:The effective rate of the observation group was 46.3%,the control group was 39%,and the difference was not statistically significant(P>0.05).The benefit rate of the observation group was 73.2%,which was significantly higher than 56.1% of the control group(P<0.05).The incidence rate of adverse reactions in the observation group was 41.5%,which was significantly lower than 60.9% of the control group(P<0.05).Conclusion:For advanced non-small cell lung cancer,using Kang Ai injection combined with chemotherapy treatment plan has a good effect.It can basically stable condition and reduce adverse reactions.